Table 2.

Odds Ratios From Logistic Regression Models^a for the Probability of Dying Between 2000 and 2006 (n = 933), Social Environment and Biomarkers of Aging Study, Taiwan

	Baseline (Model 1)		Standard Risk Factors (Model 2)		Markers of Disease Progression (Model 3)		Nonclinical Markers (Model 4)		All Biomarkers (Model 5)
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Sociodemographic factors
Age	1.117**	1.084, 1.151	1.118**	1.083, 1.155	1.074**	1.036, 1.113	1.105**	1.071, 1.140	1.062**	1.020, 1.106
Male sex	1.579	0.964, 2.589	1.759*	1.016, 3.046	1.438	0.857, 2.414	1.894*	1.102, 3.254	2.410**	1.277, 4.546
Any smoking in past 6 months	2.600**	1.617, 4.181	2.401**	1.467, 3.929	2.634**	1.594, 4.351	2.502**	1.523, 4.110	2.612**	1.510, 4.516
Standard risk factors
Hypertension
Normal (referent)			1						1
Prehypertension			0.903	0.471, 1.731					0.948	0.471, 1.911
Stage 1 hypertension			0.746	0.383, 1.452					0.728	0.354, 1.496
Stage 2 hypertension			1.404	0.691, 2.854					1.544	0.716, 3.329
Use of antihypertensive medication			0.834	0.499, 1.395					0.821	0.467, 1.445
Total cholesterol
Desirable (referent)			1						1
Borderline high			0.772	0.486, 1.224					0.866	0.525, 1.429
High			1.359	0.755, 2.444					1.630	0.843, 3.153
High density lipoprotein cholesterol
Low (referent)			1						1
Normal			0.707	0.449, 1.114					0.755	0.460, 1.240
High			0.745	0.403, 1.376					0.614	0.314, 1.201
Body mass indexb
Underweight			2.808*	1.205, 6.542					1.840	0.728, 4.652
Normal (referent)			1						1
Overweight			0.891	0.525, 1.514					1.188	0.655, 2.156
Obese			0.743	0.381, 1.449					1.332	0.616, 2.879
High waist circumference			1.262	0.739, 2.154					1.606	0.887, 2.908
Glycosylated hemoglobin			1.192	0.988, 1.440					1.156	0.939, 1.423
Use of hypoglycemic agents			0.989	0.466, 2.096					1.156	0.515, 2.595
Markers of disease progression
Creatinine clearance					0.922**	0.874, 0.971			0.914**	0.864, 0.968
Creatinine clearance squared					1.000*	1.000, 1.001			1.000*	1.000, 1.001
Albumin					0.355**	0.177, 0.715			0.428*	0.197, 0.930
White blood cell count					0.581	0.325, 1.040			0.557	0.297, 1.044
White blood cell count squared					1.047*	1.006, 1.089			1.042	0.998, 1.087
Neutrophils					1.027*	1.004, 1.050			1.021	0.996, 1.047
Nonclinical markers
Epinephrine							0.884	0.741, 1.054	0.906	0.749, 1.094
Epinephrine squared							1.020**	1.005, 1.035	1.018*	1.002, 1.034
Norepinephrine							1.004	0.984, 1.025	1.020	0.997, 1.043
Cortisol							1.005	0.999, 1.011	1.006*	1.000, 1.013
Dehydroepiandrosterone sulfate							1.000	0.995, 1.004	1.000	0.996, 1.005
Interleukin-6							1.350**	1.183, 1.541	1.235**	1.064, 1.434
Interleukin-6 squared							0.991**	0.984, 0.997	0.993	0.987, 1.000
Insulin-like growth factor 1							0.999	0.995, 1.004	0.999	0.994, 1.004
Log-likelihood	−350.7		−339.6		−327.2		−326.2		−299.8
AUC	0.79		0.80		0.82		0.82		0.85
P value from AUC test (vs. model 1)			0.0240		0.0017		0.0027		0.0000

Abbreviations: AUC, area under the receiver operating characteristic curve; CI, confidence interval; OR, odds ratio.

* P < 0.05 (2-sided); **P < 0.01 (2-sided).

^aModels included a random-effect term for the primary sampling units and adjustment for mainlander status, education, urban residence, current chronic conditions, mobility limitations, cognitive function, Center for Epidemiologic Studies Depression Scale (47) score, and self-assessed health status. For definitions of variables, see Table 1.

^bWeight (kg)/height (m)².